Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc

Bullboard Posts

Post by carduon Jun 19, 2014 12:29pm

522 Views

Post# 22675733

Way to go Singing!

I understand that you were at the AGM, refusing to identify yourself, and made a complete ass of yourself. The comments from people who heard you were: "time hugging moron who used up most of the question period", "some idiot who went on about BT manipulating the SP", "someone who went on and on about a conspiracy by the MMs". You really made your point with complete paranoia.

Please get yourself help.

Bullboard Posts

Covalon Technologies posts third profitable quarter in a row